Christine Marie Utter, the SVP of $PTCT, sold 1,381 shares of the company on 01-06-2026 for an estimated $106,267. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.8% of their shares of this class of stock. Following this trade, they now own 74,962 shares of this class of $PTCT stock.
$PTCT Insider Trading Activity
$PTCT insiders have traded $PTCT stock on the open market 141 times in the past 6 months. Of those trades, 0 have been purchases and 141 have been sales.
Here’s a breakdown of recent trading of $PTCT stock by insiders over the last 6 months:
- NEIL GREGORY ALMSTEAD (CHIEF TECHNICAL OPS OFFICER) has made 0 purchases and 34 sales selling 164,911 shares for an estimated $12,673,037.
- ERIC PAUWELS (CHIEF BUSINESS OFFICER) has made 0 purchases and 27 sales selling 106,991 shares for an estimated $7,374,415.
- MARK ELLIOTT BOULDING (EXEC. VP AND CLO) has made 0 purchases and 36 sales selling 90,054 shares for an estimated $5,776,402.
- EMMA REEVE has made 0 purchases and 19 sales selling 75,733 shares for an estimated $5,163,979.
- ALLAN STEVEN JACOBSON has made 0 purchases and 12 sales selling 39,667 shares for an estimated $2,995,618.
- MATTHEW B. KLEIN (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 5 sales selling 30,421 shares for an estimated $2,076,524.
- GLENN JR MD PHD STEELE sold 12,000 shares for an estimated $916,199
- DAVID P SOUTHWELL sold 12,000 shares for an estimated $700,080
- PIERRE GRAVIER (CHIEF FINANCIAL OFFICER) has made 0 purchases and 2 sales selling 4,655 shares for an estimated $289,037.
- CHRISTINE MARIE UTTER (SVP, CHIEF ACCOUNTING OFFICER) has made 0 purchases and 2 sales selling 2,616 shares for an estimated $201,918.
- LEE SCOTT GOLDEN (EVP & CHIEF MEDICAL OFFICER) has made 0 purchases and 2 sales selling 1,982 shares for an estimated $152,855.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PTCT Hedge Fund Activity
We have seen 155 institutional investors add shares of $PTCT stock to their portfolio, and 139 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JEFFERIES FINANCIAL GROUP INC. added 1,584,678 shares (+inf%) to their portfolio in Q3 2025, for an estimated $97,251,688
- ARMISTICE CAPITAL, LLC removed 1,458,192 shares (-30.8%) from their portfolio in Q3 2025, for an estimated $89,489,243
- POINT72 ASSET MANAGEMENT, L.P. added 1,220,642 shares (+inf%) to their portfolio in Q3 2025, for an estimated $74,910,799
- CITADEL ADVISORS LLC added 810,532 shares (+88.1%) to their portfolio in Q3 2025, for an estimated $49,742,348
- TORONTO DOMINION BANK added 800,567 shares (+32.7%) to their portfolio in Q3 2025, for an estimated $49,130,796
- MORGAN STANLEY removed 743,922 shares (-63.9%) from their portfolio in Q3 2025, for an estimated $45,654,493
- MILLENNIUM MANAGEMENT LLC added 672,079 shares (+174.8%) to their portfolio in Q3 2025, for an estimated $41,245,488
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PTCT Analyst Ratings
Wall Street analysts have issued reports on $PTCT in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 08/20/2025
- Morgan Stanley issued a "Overweight" rating on 08/20/2025
- Wells Fargo issued a "Overweight" rating on 08/20/2025
- UBS issued a "Buy" rating on 07/29/2025
- Truist Securities issued a "Buy" rating on 07/29/2025
- Cantor Fitzgerald issued a "Overweight" rating on 07/29/2025
To track analyst ratings and price targets for $PTCT, check out Quiver Quantitative's $PTCT forecast page.
$PTCT Price Targets
Multiple analysts have issued price targets for $PTCT recently. We have seen 13 analysts offer price targets for $PTCT in the last 6 months, with a median target of $76.0.
Here are some recent targets:
- Brian Abrahams from RBC Capital set a target price of $91.0 on 12/01/2025
- Gena Wang from Barclays set a target price of $68.0 on 11/06/2025
- Geoff Meacham from Citigroup set a target price of $75.0 on 11/05/2025
- Paul Choi from Goldman Sachs set a target price of $50.0 on 11/05/2025
- Benjamin Burnett from Wells Fargo set a target price of $93.0 on 11/05/2025
- Joseph Thome from TD Cowen set a target price of $63.0 on 11/05/2025
- Kelly Shi from Jefferies set a target price of $77.0 on 10/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
